Serotype distribution and susceptibility of Streptococcus pneumoniae isolates from pleural fluid in Spain from 1997 to 2008

Antimicrobial Agents and Chemotherapy

Volumn 54, Issue 12, 2010, Pages 5387-5390

  Fenoll, A ^a   Aguilar, L ^b   Vicioso, M D ^a   Gimenez, M J ^b   Robledo, O ^a   Granizo, J J ^c   Mendez, C ^d  

^a INSTITUTO DE SALUD CARLOS III   (Spain)

^b SCHOOL OF MEDICINE   (Spain)

^c Grana Datos   (Spain)

^d PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; CEFOTAXIME; ERYTHROMYCIN; LEVOFLOXACIN; PENICILLIN G;

ADULT; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; CHILD; HUMAN; NONHUMAN; PLEURA FLUID; PRIORITY JOURNAL; SEROTYPE; SPAIN; STREPTOCOCCUS PNEUMONIA; STREPTOCOCCUS PNEUMONIAE;

ADOLESCENT; ADULT; BODY FLUIDS; CEFOTAXIME; HUMANS; OFLOXACIN; PENICILLINS; PLEURAL EFFUSION; SEROTYPING; STREPTOCOCCUS PNEUMONIAE; YOUNG ADULT;

EID: 78649658359     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00217-10     Document Type: Article

References (19)

1. Ardanuy, C., D. Rolo, A. Fenoll, D. Tarrago, L. Calatayud, and J. Liñares. 2009. Emergence of a multidrug-resistant clone (ST320) among invasive serotype 19A pneumococci in Spain. J. Antimicrob. Chemother. 64:507-510.
2. Byington, C. L., K. G. Hulten, K. Ampofo, X. Sheng, A. T. Pavia, A. J. Blaschke, M. Pettigrew, K. Korgenski, J. Daly, and E. O. Mason. 2010. Molecular epidemiology of pediatric pneumococcal empyema from 2001 to 2007 in Utah. J. Clin. Microbiol. 48:520-525.
3. Byington, C. L., K. Korgenski, J. Daly, K. Ampofo, A. Pavia, and E. O. Mason. 2006. Impact of the pneumococcal conjugate vaccine on pneumococcal parapneumonic empyema. Pediatr. Infect. Dis. J. 25:250-254.
4. Calbo, E., A. Diaz, E. Canadell, J. Fabrega, S. Uriz, M. Xercavins, M. A. Morera, E. Cuchi, M. Rodriguez-Carballeira, and J. Garau. 2006. Invasive pneumococcal disease among children in a health district of Barcelona: early impact of pneumococcal conjugate vaccine. Clin. Microbiol. Infect. 12:867-872.
5. Clinical and Laboratory Standards Institute. 2006. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, seventh edition. Approved standard M7-A7. CLSI, Wayne, PA.
6. Clinical and Laboratory Standards Institute. 2009. Performance standards for antimicrobial susceptibility testing: nineteenth informational supplement M100-S19. CLSI, Wayne, PA.
7. Eastham, K. M., R. Freeman, A. M. Kearns, G. Eltringham, J. Clark, J. Leeming, and D. A. Spencer. 2004. Clinical features, aetiology and outcome of empyema in children in the north east of England. Thorax 59:522-525.
8. Fenoll, A., L. Aguilar, J. J. Granizo, M. J. Giménez, L. Aragoneses-Fenoll, C. Mendez, and D. Tarragó. 2008. Has the licensing of respiratory quinolones for adults and the 7-valent pneumococcal conjugate vaccine (PCV-7) for children had herd effects with respect to antimicrobial non-susceptibility in invasive Streptococcus pneumoniae? J. Antimicrob. Chemother. 62:1430-1433.
9. Fenoll, A., L. Aguilar, O. Robledo, M. J. Giménez, J. J. Granizo, D. Biek, and D. Tarragó. 2008. In vitro activity of ceftaroline against Streptococcus pneumoniae isolates exhibiting resistance to penicillin, amoxicillin, and cefotaxime. Antimicrob. Agents Chemother. 52:4209-4210.
10. Fenoll, A., M. J. Giménez, M. D. Vicioso, J. J. Granizo, O. Robledo, and L. Aguilar. 2009. Susceptibility of pneumococci causing meningitis in Spain and prevalence among such isolates of serotypes contained in the 7-valent pneumococcal conjugate vaccine. J. Antimicrob. Chemother. 64:1338-1340.
11. Fenoll, A., I. Jado, D. Vicioso, and J. Casal. 1997. Dot blot assay for the serotyping of pneumococci. J. Clin. Microbiol. 35:764-766.
12. Fenoll, A., C. Martín Bourgon, R. Muñóz, D. Vicioso, and J. Casal. 1991. Serotype distribution and antimicrobial resistance of Streptococcus pneumoniae isolates causing systemic infections in Spain, 1979-1989. Rev. Infect. Dis. 13:56-60.
13. Grupo de Trabajo de la Ponencia de Registro y Programa de Vacunas. 2006. Enfermedad invasora por Streptococcus pneumoniae. Implicación de la vacunación con la vacuna conjugada heptavalente. Ministerio de Sanidad y Consumo, Madrid, Spain.
14. Hausdorff, W. P., D. R. Feikin, and K. P. Klugman. 2005. Epidemiological differences among pneumococcal serotypes. Lancet Infect. Dis. 5:83-93.
15. Li, S. T., and D. J. Tancredi. 2010. Empyema hospitalizations increased in U.S. children despite pneumococcal conjugate vaccine. Pediatrics 125:26-33.
16. Muñoz-Almagro, C., I. Jordan, A. Gene, C. Latorre, J. J. Garcia-Garcia, and R. Pallares. 2008. Emergence of invasive pneumococcal disease caused by nonvaccine serotypes in the era of 7-valent conjugate vaccine. Clin. Infect. Dis. 46:174-182.
17. Obando, I., C. Muñoz-Almagro, L. A. Arroyo, D. Tarragó, D. Sanchez-Tatay, D. Moreno-Perez, S. S. Dhillon, C. Esteva, S. Hernández-Bou, J. J. García-García, W. P. Hausdorff, and A. B. Brueggemann. 2008. Pediatric parapneumonic empyema, Spain. Emerg. Infect. Dis. 14:1390-1397.
18. Singleton, R. J., T. W. Hennessy, L. R. Bulkow, L. L. Hammitt, T. Zulz, D. A. Hurlburt, J. C. Butler, K. Rudolph, and A. Parkinson. 2007. Invasive pneumococcal disease caused by nonvaccine serotypes among Alaska native children with high levels of 7-valent pneumococcal conjugate vaccine coverage. JAMA 297:1784-1792.
19. Whitney, C. G., M. M. Farley, J. Hadler, L. H. Harrison, N. M. Bennett, R. Lynfield, A. Reingold, P. R. Cieslak, T. Pilishvili, D. Jackson, R. R. Facklam, J. H. Jorgensen, A. Schuchat, and the Active Bacterial Core Surveillance of the Emerging Infections Program Network. 2003. Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine. N. Engl. J. Med. 348:1737-1746.